HealthCore, Inc., Wilmington, Delaware, USA.
RTI Health Solutions, Waltham, Massachusetts, USA.
Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):918-926. doi: 10.1002/pds.5257. Epub 2021 May 5.
To use medical record adjudication and predictive modeling methods to develop and validate an algorithm to identify anaphylaxis among adults with type 2 diabetes (T2D) in administrative claims.
A conventional screening algorithm that prioritized sensitivity to identify potential anaphylaxis cases was developed and consisted of diagnosis codes for anaphylaxis or relevant signs and symptoms. This algorithm was applied to adults with T2D in the HealthCore Integrated Research Database (HIRD) from 2016 to 2018. Clinical experts adjudicated anaphylaxis case status from redacted medical records. We used confirmed case status as an outcome for predictive models developed using lasso regression with 10-fold cross-validation to identify predictors and estimate the probability of confirmed anaphylaxis.
Clinical adjudicators reviewed medical records with sufficient information from 272 adults identified by the anaphylaxis screening algorithm, which had an estimated Positive Predictive Value (PPV) of 65% (95% confidence interval [CI]: 60%-71%). The predictive model algorithm had a c-statistic of 0.95. The model's probability threshold of 0.60 excluded 89% (84/94) of false positives identified by the screening algorithm, with a PPV of 94% (95% CI: 91%-98%). The model excluded very few true positives (15 of 178), and identified 92% (95% CI: 87%-96%) of the cases selected by the screening algorithm.
Predictive modeling techniques yielded an accurate algorithm with high PPV and sensitivity for identifying anaphylaxis in administrative claims. This algorithm could be considered in future safety studies using similar claims data to reduce potential outcome misclassification.
使用医疗记录审核和预测建模方法开发和验证一种算法,以识别 2 型糖尿病(T2D)成年患者的过敏反应。
开发了一种常规筛选算法,该算法优先考虑敏感性以识别潜在的过敏反应病例,包括过敏或相关症状和体征的诊断代码。该算法应用于 2016 年至 2018 年 HealthCore 综合研究数据库(HIRD)中的 T2D 成年患者。临床专家根据删节后的医疗记录裁定过敏反应病例的状态。我们使用拉索回归和 10 倍交叉验证开发的预测模型来识别预测因子并估计确认过敏反应的概率,将确诊病例状态作为结果。
临床审核员根据过敏筛选算法确定的 272 名成年人的医疗记录进行了审查,该记录具有 65%(95%置信区间[CI]:60%-71%)的估计阳性预测值(PPV)。预测模型算法的 C 统计量为 0.95。模型的概率阈值为 0.60,排除了筛选算法确定的 89%(84/94)的假阳性,其 PPV 为 94%(95%CI:91%-98%)。模型排除了极少数真正的阳性(178 例中的 15 例),并识别了筛选算法选择的 92%(95%CI:87%-96%)的病例。
预测建模技术产生了一种准确性高、PPV 和敏感性高的算法,可用于识别行政索赔中的过敏反应。在未来使用类似索赔数据的安全性研究中,可以考虑使用该算法来减少潜在的结局错误分类。